# OnCo record vitsgen-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/vitsgen-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "vitsgen-therapeutics" ;
  schema:name "VitsGen Therapeutics"@en ;
  schema:alternateName "VitsGen Therapeutics Inc."@en, "VitsGen"@en, "Shandong VitsGen Pharmaceutical Co., Ltd."@en ;
  schema:description "VitsGen Therapeutics is a Chinese company making radioactive medicines that home in on proteins found on tumours. Its lead, 177Lu-FAP-VG11, targets FAP in the tissue around tumours and has orphan drug status for soft tissue sarcoma."@en ;
  schema:url <https://onco.cc/companies/vitsgen-therapeutics/>, <https://www.vitsgen.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.vitsgen.com/>, <https://www.vitsgen.com/News?article_id=151>, <https://www.vitsgen.com/News?article_id=149>, <https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1153626> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/sarcoma/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/lu177-radioligand-therapy/> ;
  onco:targets <https://onco.cc/targets/fap/> ;
  onco:drugs <https://onco.cc/drugs/lu177-fap-vg11/> .